Business
Britain goes on COVID-19 vaccine spending spree – The Australian Financial Review
The race is heating up among rich nations eager to get hold of stocks of as-yet unproven vaccines.
The US has booked 300 million of AstraZeneca’s first billion doses, and last week nailed a $US1.95 billion ($2.7 billion) deal with Pfizer for 100 million doses, with an option to secure an additional 500 million doses.
And the European Union is in talks with at least half a dozen developers, including Pfizer, Sanofi and Johnson & Johnson, but Reuters has reported this week that haggling continues over the price, payment method and potential liability costs.
Countries have a duty to protec…
-
Noosa News12 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News20 hours agoCountdown on for Noosa Eat & Drink Festival 2025
-
Noosa News17 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News18 hours agoThe Trailer for ‘The Bear’ Season Four Is Here — and It’s Cooking Up a Race to Keep Carmy and Syd’s Restaurant Running